Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ZNTL — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

13.51

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.01

EPS Last/This Y

0.24

EPS This/Next Y

0.14

Price

4.22

Target Price

7.44

Analyst Recom

1.8

Performance Q

Upside

-636.0%

Beta

1.9

Ticker: ZNTL




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13ZNTL4.620.050.267569
2026-07-14ZNTL4.760.052.757582
2026-07-15ZNTL4.780.051.757586
2026-07-16ZNTL4.570.050.057593
2026-07-17ZNTL5.090.050.007589
2026-07-20ZNTL5.010.050.025731
2026-07-21ZNTL5.010.080.015927
2026-07-22ZNTL4.510.081.005953
2026-07-23ZNTL4.440.080.005979
2026-07-24ZNTL4.320.080.005983
2026-07-27ZNTL4.50.080.005984
2026-07-28ZNTL4.620.080.005988
2026-07-29ZNTL4.660.080.086005
2026-07-30ZNTL4.910.070.136007
2026-07-31ZNTL4.740.080.006019
2026-08-03ZNTL4.620.080.146043
2026-08-04ZNTL4.860.080.006048
2026-08-05ZNTL4.920.080.006048
2026-08-06ZNTL4.980.080.126047
2026-08-07ZNTL4.210.080.006054
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13ZNTL4.62-24.7- -1.74
2026-07-14ZNTL4.77-24.7- -1.74
2026-07-15ZNTL4.78-24.7- -1.74
2026-07-16ZNTL4.57-24.7- -1.74
2026-07-17ZNTL5.09-24.7- -1.74
2026-07-20ZNTL5.01-24.7- -1.74
2026-07-21ZNTL5.01-24.7- -1.74
2026-07-22ZNTL4.50-24.7- -1.74
2026-07-23ZNTL4.45-24.7- -1.74
2026-07-24ZNTL4.33-29.7- -1.67
2026-07-27ZNTL4.51-29.7- -1.67
2026-07-28ZNTL4.61-29.7- -1.67
2026-07-29ZNTL4.66-29.7- -1.67
2026-07-30ZNTL4.92-29.7- -1.67
2026-07-31ZNTL4.73-29.7- -1.67
2026-08-03ZNTL4.63-29.7- -1.67
2026-08-04ZNTL4.63-29.7- -1.67
2026-08-05ZNTL4.93-29.7- -1.67
2026-08-06ZNTL4.99-29.7- -1.67
2026-08-07ZNTL4.22-29.7- -1.67
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13ZNTL-0.22-1.4512.90
2026-07-14ZNTL-0.22-1.4512.90
2026-07-15ZNTL-0.22-1.4512.90
2026-07-16ZNTL-0.22-1.4512.90
2026-07-17ZNTL-0.22-1.4512.90
2026-07-20ZNTL-0.22-1.3612.90
2026-07-21ZNTL-0.22-1.3612.90
2026-07-22ZNTL-0.22-1.3612.90
2026-07-23ZNTL-0.22-1.3612.90
2026-07-24ZNTL-0.22-1.3612.90
2026-07-27ZNTL-0.22-1.3813.51
2026-07-28ZNTL-0.22-1.3813.51
2026-07-29ZNTL-0.22-1.3813.51
2026-07-30ZNTL-0.22-1.3813.51
2026-07-31ZNTL-0.22-1.3813.51
2026-08-03ZNTL-0.221.5613.51
2026-08-04ZNTL-0.221.5613.51
2026-08-06ZNTL-0.201.5613.51
2026-08-07ZNTL-0.201.5613.51
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

-0.5

Avg. EPS Est. Current Quarter

-0.48

Avg. EPS Est. Next Quarter

-0.49

Insider Transactions

-0.2

Institutional Transactions

1.56

Beta

1.9

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

19

Sentiment Score

95

Actual DrawDown %

95.2

Max Drawdown 5-Year %

-98.8

Target Price

7.44

P/E

Forward P/E

PEG

P/S

P/B

1.64

P/Free Cash Flow

EPS

-1.74

Average EPS Est. Cur. Y​

-1.67

EPS Next Y. (Est.)

-1.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.35

Return on Equity vs Sector %

-95.3

Return on Equity vs Industry %

-79.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

ZNTL Healthcare
$4.22
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
12/25
Volume
3/15
Valuation
10/20
TP/AR
3/10
Options
8/10
RSI
42.7
Range 1M
14.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
24 /100
WEAK
Momentum
2/25
Growth
7/30
Estimates
2/20
Inst/Vol
5/15
Options
8/10
EPS Yr
-3.4%
52W%
53%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +76.3% upside
Quality
3/30
Valuation
14/30
Growth
4/25
Stability
7/10
LT Trend
0/5
Upside
+76.3%
Quality
4
ZNTL — P/E HistoricalBiotechnology
Zentalis Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 106
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.
ZNTL

Latest News

Caricamento notizie per ZNTL
stock quote shares ZNTL – Zentalis Pharmaceuticals, Inc. Stock Price stock today
news today ZNTL – Zentalis Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ZNTL – Zentalis Pharmaceuticals, Inc. yahoo finance google finance
stock history ZNTL – Zentalis Pharmaceuticals, Inc. invest stock market
stock prices ZNTL premarket after hours
ticker ZNTL fair value insiders trading